STATE STREET CORP - TOKAI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TOKAI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$115,000
-15.4%
137,129
-0.9%
0.00%
Q4 2016$136,000
+11.5%
138,329
+72.1%
0.00%
Q3 2016$122,000
-72.2%
80,357
+1.0%
0.00%
Q2 2016$439,000
-9.9%
79,596
-8.3%
0.00%
Q1 2016$487,000
-31.0%
86,767
+7.2%
0.00%
Q4 2015$706,000
-4.5%
80,913
+13.2%
0.00%
Q3 2015$739,000
-1.6%
71,497
+27.0%
0.00%
Q2 2015$751,000
+46.7%
56,303
+24.2%
0.00%
Q1 2015$512,000
+22.8%
45,349
+60.1%
0.00%
Q4 2014$417,00028,3290.00%
Other shareholders
TOKAI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Green Owl Capital Management, LLC 130,000$1,729,0001.23%
Novo Holdings A/S 1,238,252$16,469,0001.18%
Perceptive Advisors 485,338$6,455,0000.39%
KINGDON CAPITAL MANAGEMENT, L.L.C. 740,978$9,855,0000.38%
Tourbillon Capital Partners, L.P. 517,000$6,876,0000.15%
SABBY MANAGEMENT, LLC 128,041$1,703,0000.06%
Alyeska Investment Group, L.P. 613,134$8,154,0000.05%
ROPES WEALTH ADVISORS LLC 6,000$80,0000.04%
OPPENHEIMER & CO INC 12,048$160,0000.00%
FRANKLIN RESOURCES INC 451,700$6,008,0000.00%
View complete list of TOKAI PHARMACEUTICALS INC shareholders